Revascularization With Modification Using Definitive IVL and Serration Remodeling for Optimal Lumen

Starting soon · Not applicable

Conditions studied: Peripheral Artery Disease

In brief

The objective of this first-in-human study is to assess the safety and effectiveness of the Serranator Sonic Intravascular Lithotripsy (IVL) System™ for the treatment of peripheral artery disease.

Key facts

Study ID

NCT07575568

Run by

Cagent Vascular LLC

People needed

30

Starts

2026-05-01

Expected to finish

2027-09-01

Last updated by the study team

2026-05-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.